September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, CRUK, Cancer, GSK, diagnosis, genetics, oncology, pharma

September 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance

August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
August 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

August 31, 2018 Medical Communications Orphan Drugs, analysis, dermatology, market reports, rare diseases

August 31, 2018 Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale

August 31, 2018 Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance

August 31, 2018 Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma
August 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon

August 30, 2018 Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma

August 30, 2018 Medical Communications FDA, opioid crisis, prescriptions, scott gottleib

August 28, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines

August 24, 2018 Medical Communications, Sales and Marketing Dompe, FDA, Oxervate, eye disease, pharma

August 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10